Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
Maria Rita Milone(Centro di Riferimento Oncologico), Alfredo Budillon(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 63
Related Papers
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
|Journal of Experimental & Clinical Cancer Research|2019|125
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
|British Journal of Cancer|2010|49
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
|Journal of Experimental & Clinical Cancer Research|2022|42